Nirvana Life Sciences Inc. (CNSX:NIRV) entered into a letter of intent to acquire Medsmart Dispensary Inc. for $0.13 million on November 21, 2022. Nirvana Life Sciences Inc. has entered into a definitive agreement to acquire Medsmart Dispensary Inc. on June 7, 2023. Nirvana Life Sciences Inc. acquired Medsmart in exchange for 5 million shares of Nirvana valued at $0.10 per share.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.04 CAD | -20.00% | -.--% | +100.00% |
1st Jan change | Capi. | |
---|---|---|
+100.00% | 1.41M | |
+46.02% | 54.63B | |
-6.60% | 39.92B | |
+37.07% | 38.82B | |
+13.26% | 26.86B | |
-11.17% | 26.22B | |
-21.63% | 18.78B | |
+25.24% | 12.21B | |
+0.39% | 12.16B | |
+25.73% | 11.94B |
- Stock Market
- Equities
- NIRV Stock
- News Nirvana Life Sciences Inc.
- Nirvana Life Sciences Inc. entered into a letter of intent to acquire Medsmart Dispensary Inc. for $0.13 million.